UK: final stage of Human Tissue Bill:
This article was originally published in Clinica
The UK's Human Tissue Bill has completed its passage through parliament and now awaits Royal Assent. It was passed by the House of Commons on November 10, after a debate (see Clinica Nos 1097, p 6 and 1105, p 8) that saw it through the House of Lords at its third reading.
You may also be interested in...
House and Senate Democrats sponsor legislation to authorize FTC enforcement against sales of "consumer goods and services at an unconscionably excessive price during the" COVID-19 pandemic. "It’s outrageous that some companies and individuals are taking advantage of consumers by price-gouging," says Energy and Commerce Committee Chairman Frank Pallone.
Robert Califf, a former FDA commissioner turned Verily Life Sciences exec, is just one of the voice predicting a long-term impact on clinical trial processes from the COVID-19 outbreak.
A US National Academies meeting on digital health technology showcased the communication gap between regulators and tech developers when it comes to important concepts like “digital biomarkers.”